The majority of the $2.52 billion in funding, roughly $1.7 billion, went toward companies focused on disease diagnosis. The second most-funded genomics sector was biotechnology at $550 million.
Here are the five genomics companies that received the most VC funding during the fourth quarter of 2017.
1. Menlo Park, Calif.-based Grail: $238 million
2. South San Francisco, Calif.-based Counsyl: $80 million
3. Baltimore-based Personal Genome Diagnostics: $65 million
4. Burlingame, Calif.-based Color Genomics: $37 million
5. Atlanta-based Prelude Fertility: $10 million
More articles on data analytics & precision medicine:
Report: 5 states with highest, lowest demand for data science jobs
Indiana U to launch statewide addiction database project
Survey: More than 80% of payers integrate social determinants of health data into programs
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
